The Relationship of the H Specificity to the ABO Blood Groups

Vox Sanguinis ◽  
1972 ◽  
Vol 22 (2) ◽  
pp. 97-106
Author(s):  
A.S. Wiener ◽  
W.W. Socha ◽  
E.B. Gordon
Keyword(s):  
Blood Groups ◽  
Abo Blood Groups ◽  
Relationship Of ◽  
The Relationship

The Relationship of theHSpecificity to the ABO Blood Groups

Vox Sanguinis ◽  
1972 ◽  
Vol 22 (2) ◽  
pp. 97-106 ◽  
Author(s):  
A. S. Wiener ◽  
W. W. Socha ◽  
E. B. Gordon
Keyword(s):  
Blood Groups ◽  
Abo Blood Groups ◽  
Relationship Of ◽  
The Relationship

scholarly journals The Relationship of the ABO Blood Groups to Duodenal and Gastric Ulceration

BMJ ◽  
1955 ◽  
Vol 2 (4940) ◽  
pp. 643-646 ◽  
Author(s):  
C. A. Clarke ◽  
W. K. Cowan ◽  
J. W. Edwards ◽  
A. W. Howel-Evans ◽  
R. B. McConnell ◽  
...  
Keyword(s):  
Blood Groups ◽  
Gastric Ulceration ◽  
Abo Blood Groups ◽  
Relationship Of ◽  
The Relationship

scholarly journals EVALUATION OF THE RELATIONSHIP OF ABO BLOOD GROUPS WITH MIS-C

2021 ◽  
Vol 43 ◽  
pp. S27-S28
Author(s):  
Fatma Burçin KURTİPEK ◽  
Ahmet Vedat KAVURT ◽  
Elif ÇELİKEL ◽  
Emel UYAR ◽  
Emine AZAK ◽  
...  
Keyword(s):  
Blood Groups ◽  
Abo Blood Groups ◽  
Relationship Of ◽  
The Relationship

scholarly journals ABO Blood Groups and Risk of Glioma

2021 ◽  
Author(s):  
Ana Azanjac Arsic
Keyword(s):  
Blood Group ◽  
Blood Groups ◽  
Abo Blood Groups ◽  
Increased Risk ◽  
Hereditary Factors ◽  
The One ◽  
Von Willebrand ◽  
Relationship Of ◽  
The Relationship

Gliomas are one of the most common primary brain tumors and the etiology of gliomas remains unknown in most cases. The aim of this case–control study was to investigate possible association between incidence in relation to glioma and certain blood groups. This study included 100 histopathologically verified cases of glioma and 200 age and sex-matched controls without malignant diseases that were admitted to the same hospital. The results revealed that the patients with group AB were at 3.5-fold increased risk of developing glioma compared to the patients with other ABO blood groups. In this particular study, there was more male patients with glioma with the blood group AB. However, mechanisms that explain the relationship between the blood groups ABO and a cancer risk are unclear. Several hypotheses have been proposed, including the one with a modulatory role of blood group ABO antigens. In addition, the blood group ABO system regulates the level of circulating proinflammatory and adhesion molecules which play a significant role in the tumorigenesis process. Additionally, the recent discovery that includes the von Willebrand factor (vWF) as an important modulator of angiogenesis and apoptosis provides one plausible explanation as regards the role of the blood group ABO in the tumorigenesis process. To our knowledge, this is the first study that examined the relationship of blood group in patients diagnosed with glioma among the Serbian population. Moreover, for the first time our study results suggested that blood group AB increased the risk of glioma. The results of this study suggested that the blood group AB could be one of hereditary factors which had an influence on the occurrence of glioma. The further research is needed on a larger sample, to confirm these findings and the possible mechanisms by which the ABO system contributes to the pathology of glioma.

The Relationship of the H Substance to the A–B–O Blood Groups

1966 ◽  
Vol 29 (1) ◽  
pp. 82-100 ◽  
Author(s):  
A.S. Wiener ◽  
J. Moor-Jankowski ◽  
E.B. Gordon
Keyword(s):  
Blood Groups ◽  
Relationship Of ◽  
The Relationship

scholarly journals Assessment of relationship of ABO blood groups in oral cancer patients - A retrospective study

2021 ◽  
Vol 11 (1) ◽  
pp. 80
Author(s):  
Pradhuman Verma ◽  
Avinash Kumar ◽  
Shantanu Dixit ◽  
Kratika Mohan ◽  
Nidhi Gupta ◽  
...  
Keyword(s):  
Retrospective Study ◽  
Oral Cancer ◽  
Cancer Patients ◽  
Blood Groups ◽  
Abo Blood Groups ◽  
Oral Cancer Patients ◽  
Relationship Of

scholarly journals The relationship between ABO blood groups and acne vulgaris

2016 ◽  
Vol 4 (1) ◽  
pp. 26 ◽  
Author(s):  
�mit Türsen ◽  
Erdinç Terzi ◽  
Belma Türsen ◽  
Pınar Dursun ◽  
Teoman Erdem
Keyword(s):  
Acne Vulgaris ◽  
Blood Groups ◽  
Abo Blood Groups ◽  
The Relationship

scholarly journals Elucidating the Thrombogenic Risk of Non-O Blood Groups in Children with Acute Lymphoblastic Leukemia (ALL): Is Von Willebrand Factor a Culprit ?

Blood ◽  
2016 ◽  
Vol 128 (22) ◽  
pp. 4990-4990
Author(s):  
Terry Mizrahi ◽  
Caroline Laverdière ◽  
Michele David ◽  
Jean-Marie Leclerc ◽  
Lehana Thabane ◽  
...  
Keyword(s):  
Risk Factors ◽  
Blood Group ◽  
Lymphoblastic Leukemia ◽  
Blood Groups ◽  
Older Age ◽  
Abo Blood Group ◽  
Abo Blood Groups ◽  
Increased Risk ◽  
Von Willebrand ◽  
The Relationship

Abstract Background: Individuals with non-O blood group are shown to have increased risk of thromboembolism (TE). The exact pathogenesis of the prothrombotic effect of non-O blood group, is however not known. Because individuals with O-blood group have low levels of von Willebrand factor (vWF) compared to those with non-O blood group, vWF has been contemplated as a pathogenetic mechanism in ABO blood group-related prothrombotic risk. However, the available data regarding the role of vWF in the thrombotic risk of non-O blood group are inconclusive. Children with acute lymphoblastic leukemia (ALL) are at increased risk of TE. Several factors such as older age, leukemia phenotype and asparaginase have been shown to impact the risk of TE in children with ALL. We have recently shown that non-O blood group and circulating blasts were significant risk factors for TE in children with ALL. We have also shown that at diagnosis of ALL patients with circulating blasts have significantly higher levels of vWF compared to those without circulating blasts.  Within the context of a larger study aimed to define risk factors for symptomatic TE (sTE) in children with de novo ALL, we undertook a sub-study to evaluate the relationship of ABO blood groups and vWF level at diagnosis of ALL, and to evaluate the impact of circulating blasts on the vWF levels in children with O and non-O blood groups. We hypothesized that compared to patients with O-blood group, those with non-O blood group will have significantly higher levels of vWF and that circulating blasts will have additive effect on the vWF levels in patients with non-O blood group.  Methods : The multicenter, prospective, analytical cohort study included consenting patients (1-≤18 yrs. of age) with de novo ALL enrolled on the Dana-Farber Cancer Institute 05-001 therapeutic trial. Details of patient demography including ABO blood group, ALL diagnosis, therapy and symptomatic TE (sTE) were collected. Samples collected prior to starting ALL-therapy were analyzed centrally for prothrombotic defects (PD) including [protein C, S, antithrombin, Factor VIII:C, vWF, anticardiolipin antibodies and gene polymorphisms of methylene tetrahydrofolate reductase C677T, prothrombin G20210A, Factor V Leiden]. Age-adjusted standardized laboratory data defined PD. Regression analyses evaluated relationship between risk factors and sTE. Thrombosis-free survival was estimated using Kaplan-Meier method.  Results : Of 131 enrolled patients [mean age (range) 6.4 (1-17) yrs.; 70 boys], 21 (16%) developed sTE. ABO blood group information was available for 127 patients; 51 patients had blood group O and 76 non-O (57 with blood group A, 15 with B, and 4 with AB). There was no impact of PD including vWF on the risk of sTE. Older age compared to age ≤ 5 yr. [Odds Ratio (OR) 1.9, p=0.029] and non-O blood-group (OR 4.27, p=0.028) compared to O group were identified as independent predictors for development of sTE. Patients with peripheral blasts had higher odds of developing sTE (OR 7.79; p=0.059).The sTE-free survival was affected by older age (Hazard ratio (HR) 1.1, p 0.03), ALL risk type (HR 3.0, p 0.025) and blood group (O blood group vs non-O blood group, HR 0.23, p 0.03). Table 1 compares the vWF levels in patients with O and non-O blood group and those with and without circulating blasts. Overall, there was no difference in the vWF level at ALL diagnosis between patients with O vs. Non-O blood group. Patients with circulating blasts had higher levels of vWF at ALL diagnosis compared to those without circulating blasts; this comparison was statistically significant for non-O blood group. However, there was no interaction between ABO blood group and circulating blasts on vWF levels (p=0.723)  Conclusion : There was no effect of blood group type on the vWF level at diagnosis of ALL. Patients with circulating blasts had significantly higher levels of vWF at ALL diagnosis and the vWF levels were significantly higher in patients with non-O blood group and circulating blasts. Although it is likely that the relationship between blood group and vWF may be affected by effect of circulating blasts on vWF, we showed no interaction between ABO blood groups and circulating blasts on the vWF levels at diagnosis of ALL in children. Small sample size is a limitation of current study. Further studies with larger sample size are needed to elaborate the relationship between vWF, ABO blood groups, and circulating blasts. Disclosures No relevant conflicts of interest to declare.

Sign in / Sign up

Export Citation Format

Share Document